Immunotherapy of superficial bladder cancer.
D001500:BCG Vaccine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006433:Hemocyanins / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D010844:Picibanil / Q000627:therapeutic use; D011070:Poly I-C / Q000627:therapeutic use; D011446:Prospective Studies; D011897:Random Allocation; D014165:Transfer Factor / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine; D014165:Transfer Factor; D007978:Levamisole; D010844:Picibanil; D007372:Interferons; D006433:Hemocyanins; D011070:Poly I-C